http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9628161-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 1996-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d1c163118f19318f48fdef719f408ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51a9687f77ee25aff3d76f3b6b4a93fe
publicationDate 1996-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9628161-A1
titleOfInvention Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis
abstract A topical ophthalmic composition including at least one compound of general formula (I), wherein n may be 0 or 1, m may be 2 or 3, and Het is a heteroaromatic radical of formula (a), wherein each of X, Y, Z and W, which are the same or different, is a nitrogen atom or a carbon atom attached to a hydrogen atom, a halogen atom, a methyl radical, an ethyl carboxylate radical, a carboxylic radical or a sulphonic radical, and pharmaceutically acceptable salts thereof, combined with an ophthalmically acceptable carrier, in particular for treating allergic conjunctivitis.
priorityDate 1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0507696-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0468884-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450183611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420741242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231990573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57294401

Total number of triples: 33.